Exploring factors associated with serological response to sars-cov-2 vaccines in individuals with inflammatory bowel disease: interactive visualization methods for multidimensional data

SARS-CoV-2 vaccine response may be reduced in seniors (age 65+) with inflammatory bowel disease (IBD) and those on anti-TNF therapy. A challenge of the COVID-19 era has been conveying rapid-evolving health information, especially for groups with higher risk of poor outcomes of COVID-19 such as seniors and immunocompromised individuals.

Source: Gastroenterology - January 25, 2024 Category: Gastroenterology Authors: Lindsay Hracs, Joshua Quan, Christopher Ma, Remo Panaccione, Nastaran Sharifi, Michelle Herauf, Ante Markovinovic, Stephanie Coward, Joseph Windsor, Lea Caplan, Julia Gorospe, Kenneth Ernest-Suarez, Richard Ingram, Jessalyn Holodinsky, Charles Bernstein, Source Type: research